76 related articles for article (PubMed ID: 312634)
1. Correlation between the rosette test with neuraminidase-treated sheep red blood cells and acid phosphatase activity in lymphocytes from patients with lymphoproliferative disease.
Rudzka E; Hołowiecki J; Stella-Hołowiecka B; Krawczyk M
Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):223-7. PubMed ID: 312634
[TBL] [Abstract][Full Text] [Related]
2. Acid phosphatase activity of the lymphocytes during polychemotherapy of lymphoproliferative diseases.
Rudzka E; Hołowiecki J; Japa J; Krawczyk M; Jarczok K; Stella-Hołowiecka B
Arch Immunol Ther Exp (Warsz); 1981; 29(2):133-9. PubMed ID: 6946730
[TBL] [Abstract][Full Text] [Related]
3. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
4. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
5. [Rosette tests in lymphoproliferative diseases].
Michlmayr G; Pathouli C; Falkensammer M; Huber C; Huber H; Braunsteiner H
Schweiz Med Wochenschr; 1976 Jun; 106(23):794-9. PubMed ID: 792996
[TBL] [Abstract][Full Text] [Related]
6. Increased double marker lymphocytes in systemic lupus erythematosus and lymphoproliferative disorders.
Niwa Y; Ou DW; Waterhouse JP; Yokoyama MM; Miyake S
J Clin Lab Immunol; 1982 Feb; 7(2):105-10. PubMed ID: 6978406
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte subpopulations bearing different surface markers in non-Hodgkin lymphoma.
Hołowiecki J; Japa J; Szeruda-Rudzka E; Stella-Hołowiecka B; Krawczyk M; Jarczok K; Rosa B
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):845-9. PubMed ID: 749833
[TBL] [Abstract][Full Text] [Related]
8. [Protein kinase activity in lymphoid cells in various forms of lymphoproliferative disorders].
Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
Vopr Med Khim; 1991; 37(6):30-3. PubMed ID: 1687494
[TBL] [Abstract][Full Text] [Related]
9. [Lymphoid cell glycosidases in various forms of lymphoproliferative disorders].
Ushakova NA; Vlasova AL; Preobrazhenskaia ME; Samoĭlova RS; Polianskaia AM; Grigor'eva MA; Baĭdurin SA
Vopr Med Khim; 1991; 37(6):78-82. PubMed ID: 1812621
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of tartrate-resistant acid phosphatase activity in lymphoma cells of the bone marrow].
Mariańska B; Maj S; Apel D
Acta Haematol Pol; 1985; 16(3-4):122-6. PubMed ID: 3835768
[No Abstract] [Full Text] [Related]
11. [Dynamics of immunoregulator T-lymphocytes and its importance in the chemo-immunotherapy of lymphoproliferative diseases in children].
Kadagidze ZG; Makhonova LA; Tabagari DZ; Zhogoleva IB; Maiakova SA
Vopr Onkol; 1982; 28(5):104-9. PubMed ID: 6979828
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
Chisari FV; Routenberg JA; Edgington TS
J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
[TBL] [Abstract][Full Text] [Related]
13. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
14. [Double-marker (T + B) lymphocytes in lymphoproliferative diseases].
Pecze K; Dalmi L; Rák K
Orv Hetil; 1982 Jun; 123(26):1595-7. PubMed ID: 6981087
[No Abstract] [Full Text] [Related]
15. Differentiation between chronic lymphocytic leukaemia (B-CLL) and non-Hodgkin lymphomas in the leukaemic phase by the mouse red blood cell rosette assay.
Pecze K; Telek B; Kiss A; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):446-50. PubMed ID: 2431964
[TBL] [Abstract][Full Text] [Related]
16. T-lymphocyte colonies in normal blood, bone marrow and lymphoproliferative disorders.
Foa R; Catovsky D
Clin Exp Immunol; 1979 Jun; 36(3):488-95. PubMed ID: 314868
[TBL] [Abstract][Full Text] [Related]
17. Diversity of immunological phenotypes of lymphoblastic lymphoma.
Cossman J; Chused TM; Fisher RI; Magrath I; Bollum F; Jaffe ES
Cancer Res; 1983 Sep; 43(9):4486-90. PubMed ID: 6191861
[TBL] [Abstract][Full Text] [Related]
18. [Immunological cell markers on lymphoblasts of patients with acid phosphatase positive acute leukemia (author's transl)].
Ritter J; Gaedicke G; Winkler K; Landbeck G
Z Kinderheilkd; 1975 Sep; 120(3):211-5. PubMed ID: 1080934
[TBL] [Abstract][Full Text] [Related]
19. [Acid nonspecific esterase in lymphoproliferative conditions].
Hermanský F; Benesová E; Lodrová V; Sálková J
Vnitr Lek; 1979 May; 25(5):436-42. PubMed ID: 452428
[No Abstract] [Full Text] [Related]
20. B- and T-cell markers in lymphoproliferative disorders with blood and bone marrow involvement.
Katz J; Lea R; Livni N; Lewis D; Lynch SR; Skikne B; Bezwoda W
S Afr Med J; 1978 May; 53(20):789-92. PubMed ID: 358421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
